175 related articles for article (PubMed ID: 37943200)
1. DAPT Is Comparable to OAC Following LAAC With WATCHMAN FLX: A National Registry Analysis.
Coylewright M; Holmes DR; Kapadia SR; Hsu JC; Gibson DN; Freeman JV; Yeh RW; Piccini JP; Price MJ; Allocco DJ; Nair DG
JACC Cardiovasc Interv; 2023 Nov; 16(22):2708-2718. PubMed ID: 37943200
[TBL] [Abstract][Full Text] [Related]
2. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
[TBL] [Abstract][Full Text] [Related]
3. Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillation.
Kar S; Doshi SK; Alkhouli M; Camm AJ; Coylewright M; Gibson MC; Granger CB; Gurol ME; Huber K; Mansour M; Nair DG; Natale A; Pocock SJ; Reddy VR; Saliba W; Christen T; Allocco DJ; Ellenbogen KA; Leon MB
Am Heart J; 2023 Oct; 264():123-132. PubMed ID: 37279840
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotic Therapy After Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation.
Freeman JV; Higgins AY; Wang Y; Du C; Friedman DJ; Daimee UA; Minges KE; Pereira L; Goldsweig AM; Price MJ; Reddy VY; Gibson D; Doshi SK; Varosy PD; Masoudi FA; Curtis JP
J Am Coll Cardiol; 2022 May; 79(18):1785-1798. PubMed ID: 35512858
[TBL] [Abstract][Full Text] [Related]
5. Short-term direct oral anticoagulation or dual antiplatelet therapy following left atrial appendage closure in patients with relative contraindications to chronic anticoagulation therapy.
Faroux L; Cruz-González I; Arzamendi D; Freixa X; Nombela-Franco L; Peral V; Caneiro-Queija B; Mangieri A; Trejo-Velasco B; Asmarats L; Regueiro A; McInerney A; Mas-Lladó C; Estevez-Loureiro R; Laricchia A; O'Hara G; Rodés-Cabau J
Int J Cardiol; 2021 Jun; 333():77-82. PubMed ID: 33647365
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and safety of short-term anticoagulant regimens after left atrial appendage occlusion: A systematic review and meta-analysis.
Zhou Q; Liu X; Yang X; Huang XH; Wu YZ; Tao YY; Wei M
Thromb Res; 2024 Jan; 233():88-98. PubMed ID: 38035647
[TBL] [Abstract][Full Text] [Related]
7. Left atrial appendage closure: A therapy uniquely suited for specific populations of patients with atrial fibrillation.
Black-Maier E; Piccini JP; Granger CB
J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2968-2976. PubMed ID: 31520437
[TBL] [Abstract][Full Text] [Related]
8. Antithrombotic strategies after interventional left atrial appendage closure: an update.
Chen S; Weise FK; Chun KRJ; Schmidt B
Expert Rev Cardiovasc Ther; 2018 Sep; 16(9):675-678. PubMed ID: 30095350
[TBL] [Abstract][Full Text] [Related]
9. Patient-Level Analysis of Watchman Left Atrial Appendage Occlusion in Practice Versus Clinical Trials.
Friedman DJ; Du C; Wang Y; Agarwal V; Varosy PD; Masoudi FA; Holmes DR; Reddy VY; Price MJ; Curtis JP; Freeman JV
JACC Cardiovasc Interv; 2022 May; 15(9):950-961. PubMed ID: 35512918
[TBL] [Abstract][Full Text] [Related]
10. Risk of device-related thrombosis following short-term oral anticoagulation with low-dose dabigatran versus warfarin after Watchman left atrial appendage occlusion.
Ge H; Zhang C; Qiao ZQ; Hao ZY; Li Z; Gu ZC; Jiang LS; He B; Pu J
Sci Prog; 2022; 105(3):368504221113194. PubMed ID: 35849447
[TBL] [Abstract][Full Text] [Related]
11. Rationale and design of a randomized clinical trial to compare two antithrombotic strategies after left atrial appendage occlusion: double antiplatelet therapy vs. apixaban (ADALA study).
Flores-Umanzor EJ; Cepas-Guillen PL; Arzamendi D; Cruz-González I; Regueiro A; Freixa X
J Interv Card Electrophysiol; 2020 Nov; 59(2):471-477. PubMed ID: 32986176
[TBL] [Abstract][Full Text] [Related]
12. Comparative Safety of Transcatheter LAAO With the First-Generation Watchman and Next-Generation Watchman FLX Devices.
Price MJ; Friedman DJ; Du C; Wang Y; Lin Z; Curtis JP; Freeman JV
JACC Cardiovasc Interv; 2022 Nov; 15(21):2115-2123. PubMed ID: 36357014
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of left atrial appendage occlusion versus direct oral anticoagulation in patients with atrial fibrillation and prior ischemic stroke: A propensity-score matched study.
Korsholm K; Valentin JB; Damgaard D; Diener HC; Camm AJ; Landmesser U; Hildick-Smith D; Johnsen SP; Nielsen-Kudsk JE
Int J Cardiol; 2022 Sep; 363():56-63. PubMed ID: 35780932
[TBL] [Abstract][Full Text] [Related]
14. Left Atrial Appendage Occlusion in Patients With Anticoagulation Failure vs Anticoagulation Contraindication.
Aarnink EW; Maarse M; Fierro N; Mazzone P; Beneduce A; Tondo C; Gasperetti A; Pracon R; Demkow M; Zieliński K; de Backer O; Korsholm K; Nielsen-Kudsk JE; Estévez-Loureiro R; Caneiro-Queija B; Benito-González T; Pérez de Prado A; Nombela-Franco L; Salinas P; Holmes D; Almakadma AH; Berti S; Romeo MR; Millan X; Arzamendi D; Alla VM; Agarwal H; Eitel I; Paitazoglou C; Freixa X; Cepas-Guillén P; Chothia R; Badejoko SO; Spoon DB; Maddux JT; El-Chami M; Ram P; Branca L; Adamo M; Suradi HS; Peper J; van Dijk VF; Rensing BJWM; Swaans MJ; Vireca E; Bergmann MW; Boersma LVA;
JACC Cardiovasc Interv; 2024 Jun; 17(11):1311-1321. PubMed ID: 38795093
[TBL] [Abstract][Full Text] [Related]
15. Combining Oral Anticoagulants With Platelet Inhibitors in Patients With Atrial Fibrillation and Coronary Disease.
Sindet-Pedersen C; Lamberts M; Staerk L; Nissen Bonde A; Berger JS; Pallisgaard JL; Lock Hansen M; Torp-Pedersen C; Gislason GH; Olesen JB
J Am Coll Cardiol; 2018 Oct; 72(15):1790-1800. PubMed ID: 30286922
[TBL] [Abstract][Full Text] [Related]
16. Dual antiplatelet therapy is safe and efficient after left atrial appendage closure.
Maksym J; Mazurek T; Kochman J; Grygier M; Kapłon-Cieślicka A; Marchel M; Lodziński P; Piątkowski R; Wilimski R; Czub P; Fojt A; Karolczak N; Hendzel P; Opolski G
Kardiol Pol; 2018; 76(2):459-463. PubMed ID: 29350390
[TBL] [Abstract][Full Text] [Related]
17. Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis.
Holmes DR; Doshi SK; Kar S; Price MJ; Sanchez JM; Sievert H; Valderrabano M; Reddy VY
J Am Coll Cardiol; 2015 Jun; 65(24):2614-2623. PubMed ID: 26088300
[TBL] [Abstract][Full Text] [Related]
18. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
[TBL] [Abstract][Full Text] [Related]
19. Propensity-matched comparison of antiplatelet versus anticoagulant after left atrial appendage closure with the Watchman.
Liu XX; Kleinecke C; Busch S; Allakkis W; Mohrez Y; Cheikh-Ibrahim M; Mahnkopf C; Brachmann J; Schnupp S; Gloekler S; Yu J; Ma C
Pacing Clin Electrophysiol; 2020 Nov; 43(11):1242-1251. PubMed ID: 32779203
[TBL] [Abstract][Full Text] [Related]
20. Short-term antiplatelet versus anticoagulant therapy after left atrial appendage closure: a systematic review and meta-analysis.
Zhou Q; Liu X; Gu ZC; Yang X; Huang XH; Wu YZ; Tao YY; Wei M
J Thromb Thrombolysis; 2024 Feb; 57(2):194-203. PubMed ID: 38180590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
